Endotoxin Testing in Peptide Quality Control

Sterility and endotoxin are often mentioned together on a certificate of analysis, and readers frequently assume one implies the other. It does not. A sample can be sterile, meaning no viable organisms can be cultured from it, and still carry the molecular debris those organisms left behind. Bacterial endotoxin is the most important of that debris. It is one of the most potent inflammatory molecules known, it survives the processes that kill bacteria, and it can enter a peptide product at almost any stage from raw materials to the water used in the final step. This note explains what endotoxin is, why it is measured separately, how the assays that detect it work, what the compendial chapters require, and how to read an endotoxin result on a research peptide COA.

What endotoxin is

Endotoxin is the common name for lipopolysaccharide (LPS), a large amphipathic molecule that forms the outer leaflet of the outer membrane in Gram-negative bacteria such as Escherichia coli and Pseudomonas. It has three regions: a hydrophobic lipid A anchor, a core oligosaccharide and a variable O-antigen polysaccharide chain. Lipid A is the biologically active part. It is recognized by the innate immune system through Toll-like receptor 4, and that recognition triggers the release of inflammatory cytokines. Beutler and Rietschel’s historical review traces how the substance first named “endotoxin” by Richard Pfeiffer in the 1890s was eventually identified as LPS and how its receptor was discovered a century later.¹

Two properties make endotoxin a persistent quality-control problem. It is released when bacteria die and lyse, so a process that kills contaminating organisms can increase the free endotoxin in the product. And it is extraordinarily stable: LPS tolerates autoclaving temperatures, passes through sterilizing filters because individual molecules and small aggregates are far smaller than the 0.2-micrometer pore size, and adheres to glass and plastic surfaces. Removing it requires either very high dry-heat temperatures, which peptides cannot survive, or specific depyrogenation steps applied to the containers and water before the peptide is introduced. For a lyophilized peptide, the practical strategy is prevention: using low-endotoxin water, depyrogenated glassware and clean handling, and then verifying the result by testing.

Why it is tested separately from sterility

A sterility test asks whether anything grows when the sample is incubated in culture media. An endotoxin test asks whether a specific molecule is present regardless of whether any organism is alive. The two can disagree in both directions. A sample can fail sterility because of a single Gram-positive contaminant that carries no LPS, and it can pass sterility while carrying substantial endotoxin from Gram-negative organisms that were killed earlier in processing. Because the two tests answer different questions, pharmacopeias require both for parenteral pharmaceuticals, and a research peptide COA that reports one should not be read as implying the other.

Sterile means nothing is alive in the vial. It says nothing about what was alive in it before.

The Limulus amebocyte lysate test

The standard assay for endotoxin was discovered by accident. In the early 1960s, Frederik Bang observed that the blood of the Atlantic horseshoe crab, Limulus polyphemus, clotted in response to Gram-negative bacterial infection. Jack Levin, working with Bang at the Marine Biological Laboratory, showed in 1964 that the clotting was triggered by endotoxin itself and was mediated by the crab’s circulating amebocytes.² A lysate of those cells, called Limulus amebocyte lysate or LAL, turned out to be an exquisitely sensitive endotoxin detector, and it displaced the rabbit pyrogen test in most applications over the following decades.

The biochemistry is a serine protease cascade. Endotoxin binds and activates Factor C. Activated Factor C activates Factor B. Factor B activates a proclotting enzyme, which cleaves coagulogen into coagulin, and coagulin polymerizes into a gel. Each step amplifies the signal, which is why the assay can detect endotoxin at picogram levels. Three formats are in compendial use. The gel-clot method is the original: a sample is mixed with lysate, incubated, and inverted; a firm clot is positive. The turbidimetric method measures the increase in optical density as coagulin forms. The chromogenic method replaces coagulogen with a synthetic peptide substrate that releases a colored product when cleaved, allowing quantitation by absorbance. The kinetic versions of the turbidimetric and chromogenic methods, which follow the reaction over time, give the widest quantitative range and are the most common in commercial testing.

Recombinant Factor C and recombinant cascade reagents

LAL depends on bleeding wild-caught horseshoe crabs, a practice with documented mortality and ecological consequences.³ It also introduces lot-to-lot variability, because the lysate is a natural extract whose composition depends on the animal. Both problems motivated the development of recombinant reagents. Ding and Ho, who had cloned Factor C from the Singapore horseshoe crab, described in 2001 the prospect of an endotoxin test built on recombinant Factor C alone.⁴ In the resulting assay, endotoxin activates recombinant Factor C, which cleaves a fluorogenic substrate; the signal is read directly, with no downstream cascade. Because Factor C is the only component that responds to endotoxin, the rFC assay is inherently specific and is not affected by (1,3)-beta-D-glucans, a class of fungal polysaccharide that can trigger LAL through an alternative Factor G pathway and produce false positives.

A second generation of reagents, called recombinant cascade reagents (rCR), reproduces the full three-enzyme cascade of Factor C, Factor B and proclotting enzyme using recombinant proteins, so that the assay behaves like LAL in format while avoiding the animal source. Bolden and colleagues reviewed the available recombinant reagents in 2020 and concluded that they detected environmental endotoxins comparably to LAL across the samples examined.⁵ The practical distinction is that rFC assays are fluorometric and single-step, while rCR assays are compatible with the chromogenic and turbidimetric read-outs laboratories already use.

Method	Reagent source	Read-out	Compendial status	Glucan interference
Gel-clot LAL	Horseshoe crab lysate	Visual clot, semi-quantitative	USP <85> referee method	Yes, unless glucan-blocked lysate used
Kinetic chromogenic / turbidimetric LAL	Horseshoe crab lysate	Absorbance vs. time, quantitative	USP <85>	Yes, unless glucan-blocked lysate used
Recombinant Factor C (rFC)	Recombinant protein	Fluorescence, quantitative	USP <86> (2025)	No
Recombinant cascade reagent (rCR)	Recombinant proteins	Chromogenic or turbidimetric	USP <86> (2025)	No

What USP <85> and <86> require

United States Pharmacopeia General Chapter <85> Bacterial Endotoxins Test, is the compendial standard that defines the LAL methods, the reference standard endotoxin against which reagents are calibrated, and the controls a valid test must include.⁶ Two controls matter most for interpreting a result. The first is the positive product control, in which a known quantity of endotoxin is spiked into the sample. If the spike is recovered within 50 to 200 percent of its nominal value, the sample matrix is not interfering with the assay. If it is not, the sample must be diluted or otherwise treated until it does, and the result is only valid at the dilution where recovery is acceptable. The second is the maximum valid dilution, calculated from the endotoxin limit for the product and the sensitivity of the reagent, which caps how far a sample may be diluted to overcome interference. Peptides are relevant here because some sequences, particularly cationic ones, bind LPS and suppress the signal, and a laboratory that does not run the positive product control can report a falsely low result without knowing it.

For decades, using a recombinant reagent meant validating it as an alternative method against <85> a burden that slowed adoption. That changed with General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents, which USP published for early adoption in November 2024 and made official in May 2025.⁷ The chapter describes rFC and rCR methods and their controls in the same framework as <85> giving them standalone compendial status. It does not replace LAL; the two chapters coexist and a laboratory may use either. The European Pharmacopoeia took a parallel step with chapter 2.6.32 on recombinant Factor C. For research peptide testing, the practical consequence is that a COA may legitimately report endotoxin by either an LAL method or a recombinant one, and the method should be named.

The FDA’s 2012 question-and-answer guidance on pyrogen and endotoxin testing remains the agency’s most detailed public statement on how it expects the compendial methods to be applied, including the acceptability of alternative methods once validated, the handling of interfering samples and the relationship between endotoxin limits and dose.⁸

Reading an endotoxin result

Endotoxin is quantified in endotoxin units (EU), a biological activity unit defined against the reference standard rather than a mass, because different LPS structures have different potencies per microgram. One EU is approximately equivalent to 0.1 nanograms of the reference E. coli endotoxin, although the conversion is not exact across sources. A COA typically reports EU per milligram of peptide or EU per vial, and the two are related by the vial’s net content. A result stated as “less than” a value means the sample was below the assay’s detection limit at the dilution tested, which is the usual and expected outcome for a clean lot; it is not a measurement of zero.

Pharmaceutical endotoxin limits are set per kilogram of body weight per hour for the intended dose, which is a framework that does not translate to research material with no defined use. Research peptide COAs therefore usually report the measured value against a laboratory-chosen specification, often expressed in EU per milligram. When comparing results across suppliers, the meaningful checks are whether the method is named, whether the detection limit is stated, and whether the positive product control was run and passed. A low number from an assay with a failed or unreported product control is not reliable.

Where endotoxin enters and why bacteriostatic water is not a fix

For a lyophilized peptide, endotoxin can arrive through the synthesis solvents and reagents, the purification buffers, the water used to dissolve the peptide before freeze-drying, the vials and stoppers, and the handling environment. Water is the largest single risk because Gram-negative bacteria grow readily in stored water and shed LPS as they do. Manufacturers control this by using water that meets a pharmacopeial endotoxin specification and by depyrogenating glassware with dry heat before use. Nothing added later removes endotoxin that is already present. Bacteriostatic water inhibits the growth of organisms introduced after a vial is opened; its preservative has no effect on LPS, and a low-endotoxin diluent cannot lower the endotoxin content of a peptide that already carries it. This is why endotoxin is tested on the peptide itself rather than assumed from the quality of the diluent.

For each Wednesday lot, the third-party report in the COA library lists the tests performed and the methods used. Where an endotoxin result appears, the assay format and detection limit are stated so that the number can be read in context. For how this fits alongside purity, identity and net content, see why third-party testing matters and how to read a certificate of analysis.

Frequently asked questions

What is endotoxin in peptides?

Endotoxin is lipopolysaccharide from the outer membrane of Gram-negative bacteria. It can contaminate a peptide through water, reagents or containers, survives sterilization and filtration, and is detected with the bacterial endotoxins test rather than a sterility test.

What is the LAL test?

The Limulus amebocyte lysate test uses an extract of horseshoe crab blood cells that clots or changes color in the presence of endotoxin. It exists in gel-clot, turbidimetric and chromogenic formats and is defined by USP General Chapter <85>.

What is recombinant Factor C and is it accepted?

Recombinant Factor C is a laboratory-made version of the first enzyme in the horseshoe crab clotting cascade. It detects endotoxin by cleaving a fluorescent substrate and is not affected by fungal glucans. USP General Chapter <86> official in May 2025, gives rFC and recombinant cascade reagents compendial status alongside LAL.

What does EU/mg mean on a peptide COA?

Endotoxin units per milligram of peptide. EU is a biological activity unit calibrated against a reference endotoxin. A result reported as “less than” a value means the sample was below the assay’s detection limit at the dilution tested, which is the expected outcome for a clean lot.

Does sterile mean endotoxin-free?

No. Sterility means no viable organisms grow from the sample. Endotoxin is released when bacteria die and persists after sterilization, so a sterile sample can still contain it. The two attributes are tested separately.

References & further reading

1. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3(2):169-176. doi:10.1038/nri1004 / PMID 12563300
2. Levin J, Bang FB. The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp. 1964;115:265-274. PMID 14209047
3. Maloney T, Phelan R, Simmons N. Saving the horseshoe crab: a synthetic alternative to horseshoe crab blood for endotoxin detection. PLoS Biol. 2018;16(10):e2006607. doi:10.1371/journal.pbio.2006607
4. Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol. 2001;19(8):277-281. doi:10.1016/S0167-7799(01)01694-8
5. Bolden J, Knutsen C, Levin J, et al. Currently available recombinant alternatives to horseshoe crab blood lysates: are they comparable for the detection of environmental bacterial endotoxins? A review. PDA J Pharm Sci Technol. 2020;74(5):602-611. doi:10.5731/pdajpst.2020.012187
6. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. USP-NF. uspnf.com
7. United States Pharmacopeia. General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents; FAQ. USP-NF. Official May 2025. uspnf.com/notices/86-alternative-faq
8. US Food and Drug Administration. Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers. June 2012. fda.gov